Format

Send to

Choose Destination
Diabetes Technol Ther. 2020 Feb 7. doi: 10.1089/dia.2020.0023. [Epub ahead of print]

A novel and easy method to locate and remove first approved long-term implantable glucose sensors.

Author information

1
University of Colorado at Denver - Anschutz Medical Campus, 129263, Barbara Davis Center for Diabetes, 1775 Aurora Ct, Room 1319, Aurora, Colorado, United States, 80045-0508; HALIS.AKTURK@cuanschutz.EDU.
2
Barbara Davis Center for Childhood Diabetes, 21610, Adult, Aurora, Colorado, United States; Scott.brackett@cuanschutz.edu.

Abstract

Objective Eversense is a long-term implantable continuous glucose monitoring system. Difficulty in locating and removing implanted sensors is one of the issues limiting its use. We propose using near-infrared (NIR) light to locate implanted glucose sensors. Research Design and Methods NIR light was used to locate implanted glucose sensors in 30 patients (age 18-62) with type 1 diabetes that use Eversense sensors for continuous glucose monitoring. Duration of sensor implantation was 10-40-weeks (median 12 weeks). Results Out of 30 patients with type 1 diabetes, the NIR light located the implanted sensor in 24 patients (success rate 80%) within 5 seconds. Sensor implantation at the skin with tattoos and excessive freckles were two main reasons for failure to locate sensors using NIR. Conclusions We report an innovative method to locate implanted glucose sensors in seconds which would reduce the time significantly to remove the sensor.

PMID:
32031415
DOI:
10.1089/dia.2020.0023

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center